Last updated 2026-07-23
- Raised Follow-on PO, Jul 2020
Total raised
—
Stage
Public
Founded
2006
Headcount
15
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Nextage Therapeutics is an Israeli biotech company that has developed a proprietary BTLs (Brain Targeting Liposome System) drug delivery platform for targeted nano-liposomes based drug delivery across the blood-brain-barrier. Its lead drug candidate is under development for the treatment of glioblastoma, Alzheimer's, Parkinson's, and certain cancers. Through its subsidiary, Nextar Chempharma Solutions, it also provides development and commercial manufacturing services for pharmaceuticals and medical devices, including drug substance synthesis, formulation development, scale-up, and sterile manufacturing. The company also has a focus on psychedelic substances for neurological disorders through its subsidiary Emu Life.
Funding history · 1 round · — total
2020-07
Follow-on PO
Undisclosed
Headcount over time
From 8 (2018-11) to 15 (2026-03) · +7 (+88%) · 8 points · source: Finder history + radar grounding
Q&A
- What is Nextage Therapeutics' primary focus?
- Nextage Therapeutics specializes in targeted nano-liposomes based drug delivery across the blood-brain-barrier, with a lead drug candidate under development for glioblastoma treatment.
- When was Nextage Therapeutics founded?
- Nextage Therapeutics was founded in March 2006.
- What is the current employee count for Nextage Therapeutics?
- Nextage Therapeutics has 11-50 employees.
- What is Nextage Therapeutics' market capitalization?
- Nextage Therapeutics has a market capitalization of $7,257,424 USD.
- What additional services does Nextage Therapeutics provide through its subsidiary?
- Through its subsidiary Nextar Chempharma Solutions, Nextage Therapeutics provides development and commercial manufacturing services for pharmaceuticals and medical devices, including drug substance synthesis, formulation development, and sterile manufacturing.
- What is the current status of Nextage Therapeutics?
- Nextage Therapeutics is an active company and has been public on TASE since August 2020.
- Does Nextage Therapeutics hold any patents?
- Yes, Nextage Therapeutics holds 1 patent.
- Who is the CEO of Nextage Therapeutics?
- The CEO of Nextage Therapeutics is Ilan Avni.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrug DeliveryCosmetic MaterialsDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsMedical Devices Industry
Business model
B2B
Highlights
1 PatentsVerified
Tags
pharmaceuticalsdrug-development
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | www.nxtg.co.il |
|---|---|
| linkedin.com/company/nextage-tx/ |
Identifiers & details
| Legal name | Nextage Therapeutics Ltd. |
|---|---|
| Founded | 2006-3 |
| Employees (exact) | 15 |
| Market cap | $7.3M |
| Status reason | Public on TASE on Aug 2020; |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | nxtg.co.il |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 520039181 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 1982-05-18 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 1989 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | אינשטיין 13 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-11 | עדכון חיובים במג~ק |